New stock news | Wuxi Best Precision Machinery's Hong Kong IPO and domestic unlisted shares "fully circulated" approved by the China Securities Regulatory Commission.
On July 10th, the International Cooperation Department of the China Securities Regulatory Commission issued the "Notice of Filing for the Overseas Issuance and Listing of Shares of Zhenjiang Best New Materials Co., Ltd. and the Complete Flow of Shares in the Domestic Unlisted Shares".
On July 10, the International Cooperation Department of the China Securities Regulatory Commission issued a "Notice of Filing for Overseas Issuance and Listing of Wuxi Best Precision Machinery New Materials Co., Ltd. in Zhenjiang and Full Circulation of Unlisted Shares domestically" The company plans to issue no more than 103,497,900 shares of overseas listed common stock and list on the Hong Kong Stock Exchange. 19 shareholders of the company intend to convert a total of 357,755,600 shares of domestically unlisted shares into overseas listed shares and list them for circulation on the Hong Kong Stock Exchange.
According to the prospectus, the company is a well-established electronic functional materials company with a strong market position in the areas of acoustic enhancement materials, electronic ceramic materials, electronic adhesives, and energy enhancement materials. Based on a deep understanding of industry development and technological evolution, as well as solid research and development capabilities and lean management expertise, the company has built three core technology platforms, namely the inorganic powder technology platform, polymer materials technology platform, and composite materials technology platform.
The names of the "full circulation" shareholders and the number of shares converted are as follows:
Related Articles
.png)
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.

US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.

GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.
.png)
US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.

GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.

RECOMMEND





